Latest News

Ketogenic Diet Effective and Tolerable to Reduce Seizures in Infants
Ketogenic Diet Effective and Tolerable to Reduce Seizures in Infants

December 5th 2023

Although a small-scale study, most infants had a positive response to ketogenic diet, with even greater effects seen in those with Ohtahara syndrome.

FDA Places Clinical Hold on Roche’s BTK Inhibitor Fenebrutinib for Multiple Sclerosis
FDA Places Clinical Hold on Roche’s BTK Inhibitor Fenebrutinib for Multiple Sclerosis

December 5th 2023

FDA Clears Vivos CARE Appliance for Severe Obstructive Sleep Apnea
FDA Clears Vivos CARE Appliance for Severe Obstructive Sleep Apnea

December 5th 2023

Concomitant Clobazam, Valproate Improves Ganaxolone’s Impact on Motor Seizure Frequency in CDKL5 Deficiency Disorder
Concomitant Clobazam, Valproate Improves Ganaxolone’s Impact on Motor Seizure Frequency in CDKL5 Deficiency Disorder

December 5th 2023

Gabrielle Stires, APRN-CNP, associate medical director at Biocodex
Prescription Records Reveal New Insights Into Stiripentol Use for Dravet Syndrome

December 4th 2023

AES 2023
AANEM 2023
CTAD 2023
Roundtable Discussions
NeuroVoices
Mind Moments podcast
Gold Standard Centers
EEGTalk with Fabio Nascimento, MD, and Brandon Westover, MD, PhD
Brain Games

Conference Coverage

View All
Greater Insights into Seizure Causes With Epilepsy Genetic Testing in Adults: Yi Li, MD, PhD
Greater Insights into Seizure Causes With Epilepsy Genetic Testing in Adults: Yi Li, MD, PhD

December 5th 2023

Ketogenic Diet Effective and Tolerable to Reduce Seizures in Infants
Ketogenic Diet Effective and Tolerable to Reduce Seizures in Infants

December 5th 2023

Emphasizing Patient Conversations and Treatment Opportunities for Seizure Management: Danielle Becker, MD, MS, FAES
Emphasizing Patient Conversations and Treatment Opportunities for Seizure Management: Danielle Becker, MD, MS, FAES

December 5th 2023

Concomitant Clobazam, Valproate Improves Ganaxolone’s Impact on Motor Seizure Frequency in CDKL5 Deficiency Disorder
Concomitant Clobazam, Valproate Improves Ganaxolone’s Impact on Motor Seizure Frequency in CDKL5 Deficiency Disorder

December 5th 2023

Video Series
Video Interviews
Podcasts

Most Recent

© 2023 MJH Life Sciences

All rights reserved.